The latest Investing Matters Podcast episode featuring Jeremy Skillington, CEO of Poolbeg Pharma has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCMC Markets Regulatory News (CMCX)

Share Price Information for CMC Markets (CMCX)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 260.00
Bid: 259.00
Ask: 260.00
Change: -2.00 (-0.76%)
Spread: 1.00 (0.386%)
Open: 260.00
High: 262.50
Low: 258.50
Prev. Close: 262.00
CMCX Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

H1 2020 Pre-Close Trading Update

3 Oct 2019 07:00

RNS Number : 5896O
CMC Markets Plc
03 October 2019
 

3 October 2019

CMC Markets Plc

 

H1 2020 Pre-Close Trading Update

For the six months ended 30 September 2019

 

CMC Markets Plc ("CMC" or the "Group"), a leading global provider of online trading and institutional ("B2B") platform technology solutions, today issues its pre-close trading update for the six months ended 30 September 2019 ("H1 2020" or "the period").

 

Net trading revenue for the Group was strong during the period, generated through higher valued clients and growing income from our technology ("B2B") business. Our stockbroking business revenue is expected to increase to approximately £14 million for H1 2020 (H1 2019: £5.5 million). This is mainly as a result of the revenue generated from various white label partnerships in Australia of which ANZ Bank is the largest.

 

The CFD business has generated client income (client transaction costs) only slightly down in comparison to those recorded in H1 2019, despite the prior year comparative including four months of trading pre-regulatory change in the ESMA region. This has been generated by moderately lower active client numbers than H1 2019, underlining the Group's focus on, and ongoing success in, attracting and retaining high value clients. Changes made to the internal business model have resulted in the retention of a greater proportion of client income, meaning that the Group expects the CFD business net trading revenue to be approximately £22 million higher than the £63 million reported in H1 2019 at approximately £85 million.

 

Operating costs, excluding variable remuneration, for H1 2020 will be moderately higher than the prior year, in line with previously announced full year guidance.

 

Outlook

 

Following the strong performance in H1 2020, the Board is now confident that net operating income will exceed £170 million for the full year and profit before tax is expected to increase, benefitting from the operating leverage in the business.

 

Peter Cruddas, Chief Executive Officer, commented:

 

"I am pleased with our first half performance. This time last year we had the uncertainty of regulatory change hanging over the sector and the uncertainty of how clients would react to the changes in minimum margin levels. A year on, we are seeing clients adapting to the new changes and still maintaining their interest in the products and the trading platforms we offer.

 

It is clear that we are becoming more than a CFD business with income also being derived from technology partnerships, such as the ANZ deal. This is an exciting area of the business which will continue to grow through further planned partnerships.

 

On the regulatory front, we welcome the consultation by The Australian Securities and Investments Commission ("ASIC"). The Group is supportive of regulatory change to ensure that all providers operate to the highest standards, ensuring fair client outcomes and we believe that a stronger and better industry will emerge from these changes. We anticipate the ASIC changes will come into effect in the second half of the financial year, although exact timing is still to be determined."

 

H1 2020 Results

 

The results for the six months ending 30 September 2019 will be announced on 21 November 2019.

 

A presentation for institutional investors and analysts will be held on 21 November 2019 at 10.30am GMT. For those wishing to attend in person, please contact investor.relations@cmcmarkets.com.

 

 

 

Forward looking statements

 

This trading update may include statements that are forward looking in nature. Forward looking statements involve known and unknown risks, assumptions, uncertainties and other factors which may cause the actual results, performance or achievements of the Group to be materially different from any future results, performance or achievements expressed or implied by such forward looking statements. Except as required by the Listing Rules and applicable law, the Group undertakes no obligation to update, revise or change any forward-looking statements to reflect events or developments occurring after the date such statements are published.

 

Enquiries

 

CMC Markets Plc +44 (0) 20 7170 8200

Euan Marshall, Interim Chief Financial Officer

 

Camarco +44 (0) 20 3757 4980

Geoffrey Pelham-Lane

Ed Gascoigne-Pees

Jennifer Renwick

 

Notes to Editors

 

CMC Markets Plc ("CMC"), whose shares are listed on the London Stock Exchange under the ticker CMCX (LEI: 213800VB75KAZBFH5U07), was established in 1989 and is now one of the world's leading online financial trading businesses. The company serves retail and institutional clients through regulated offices and branches in 12 countries, with a significant presence in the UK, Australia, Germany and Singapore. CMC Markets offers an award-winning, online and mobile trading platform, enabling clients to trade up to 10,000 financial instruments across shares, indices, foreign currencies, commodities and treasuries through contracts for difference ("CFDs"), financial spread bets (in the UK and Ireland only) and, in Australia, access stockbroking services. More information is available at http://www.cmcmarkets.com/group/

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
TSTZMMGGLZNGLZM
Date   Source Headline
21st Jul 20212:15 pmRNSDirector/PDMR Shareholding
13th Jul 20219:45 amRNSIssue of Equity
12th Jul 20212:23 pmRNSDirector/PDMR Shareholding
9th Jul 202112:34 pmRNSDirector/PDMR Shareholding
25th Jun 20214:46 pmRNSNotice of AGM
10th Jun 20219:58 amRNSDirector/PDMR Shareholding
10th Jun 20217:00 amRNSFinal Results
10th May 202110:15 amRNSDirector/PDMR Shareholding
9th Apr 20213:43 pmRNSDirector/PDMR Shareholding
9th Apr 20213:39 pmRNSDirector/PDMR Shareholding
25th Mar 20213:55 pmRNSBoard Committee Changes
25th Mar 20217:00 amRNSFY 2021 Pre-Close Trading Update
10th Mar 20213:00 pmRNSHolding(s) in Company
10th Mar 202111:48 amRNSDirector/PDMR Shareholding
24th Feb 20219:43 amRNSHolding(s) in Company
10th Feb 20213:01 pmRNSDirector/PDMR Shareholding
10th Feb 20212:30 pmRNSDirector/PDMR Shareholding
26th Jan 20217:00 amRNSCMC selects AWS to improve product delivery
20th Jan 20217:00 amRNSQ3 2021 Trading Update
11th Jan 202111:15 amRNSDirector/PDMR Shareholding
24th Dec 20209:55 amRNSDirector/PDMR Shareholding
24th Dec 20209:33 amRNSDirector/PDMR Shareholding
9th Dec 202011:44 amRNSDirector/PDMR Shareholding
1st Dec 202012:25 pmRNSDirector/PDMR Shareholding
23rd Nov 202011:58 amRNSDirector/PDMR Shareholding
19th Nov 20207:00 amRNSInterim results
10th Nov 202010:06 amRNSDirector/PDMR Shareholding
26th Oct 20207:00 amRNSAppointment of Joint Corporate Broker
23rd Oct 20208:44 amRNSCMC welcomes ASIC consultation paper outcome
8th Oct 20207:00 amRNSTrading Update
6th Oct 20202:51 pmRNSDirector/PDMR Shareholding
22nd Sep 20204:45 pmRNSDirector/PDMR Shareholding
17th Sep 20204:19 pmRNSDirector/PDMR Shareholding
14th Sep 20209:15 amRNSIssue of Equity
9th Sep 20204:02 pmRNSDirector/PDMR Shareholding
9th Sep 20203:58 pmRNSHolding(s) in Company
3rd Sep 20207:00 amRNSTrading Update
2nd Sep 202010:40 amRNSCompliance with Listing Rule 9.2.6E
10th Aug 202011:34 amRNSDirector/PDMR Shareholding
30th Jul 20204:08 pmRNSRESULTS OF 2020 ANNUAL GENERAL MEETING
30th Jul 20201:58 pmRNSDirector/PDMR Shareholding
20th Jul 20202:14 pmRNSHolding(s) in Company
13th Jul 20207:00 amRNSAppointment of Chief Technology Officer
8th Jul 20203:41 pmRNSDirector/PDMR Shareholding
3rd Jul 20207:00 amRNSQ1 2021 Trading Update
11th Jun 20207:00 amRNSFinal results
8th Jun 20202:59 pmRNSDirector/PDMR Shareholding
7th May 20204:44 pmRNSDirector/PDMR Shareholding
8th Apr 20208:35 amRNSDirector/PDMR Shareholding
3rd Apr 20207:00 amRNSFY 2020 Pre-Close Trading Update

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.